Pfizer Australia’s A$180 Million Acquisition of ResApp

Laura Testa
Tagged:

DLA Piper has advised ResApp Health Limited on the deal. ResApp Health Limited (ResApp) announced its A$180 million cash acquisition by Pfizer Australia Holdings Pty Limited…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here